The Low DoseThe GLP-1 price desk
Briefing

Ozari Health vs TrimRx

$125/mo against $399/mo for tirzepatide. Which is worth it, and for whom.

Illustration of two objects on a balance scale

Updated 2026-09-18

Both sell tirzepatide. Ozari Health costs $125 a month and TrimRx costs $399, a difference of $274 a month or about $3,288 a year. The desk reads it as follows.

Ozari Health is lowest advertised semaglutide price. TrimRx is all-inclusive compounded pricing. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Ozari Health advertises $125 and bills $125; TrimRx advertises $349 and bills $399. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.

Side by side

OzariTrimRx
Advertised$125$349
Billed$125$399
Gapnone+$50
Per year, billed$1,500$4,788

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

On every attribute we track these two behave identically — same answer on dose pricing, commitment, pharmacy disclosure, formats, insurance and what the price includes. When that happens the decision really is just the monthly figure, and Ozari Health is $274 a month cheaper.

What each puts on the record: Ozari Health

  • HSA and FSA accepted; no insurance billing.
  • Physician review through Arora Health, the same clinical network behind Trimi, with named medical directors.

Where it wins: The lowest advertised compounded semaglutide price we have verified. Watch for: Confirm whether $86 is a month-to-month rate or requires a longer commitment, and ask which pharmacy compounds it.

What each puts on the record: TrimRx

    Where it wins: One price covers consultation, medication and supplies. Watch for: Read the ongoing rate on the checkout screen, not the landing page. Reported billing is $399/month.

    In each one’s favour

    Ozari Health.

    • The lowest advertised compounded semaglutide price we have verified.
    • No membership fee and free expedited shipping included.

    TrimRx.

    • One price covers consultation, medication and supplies.
    • No separate membership fee.

    Ozari Health scores higher overall at 4.4 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

    The desk’s call

    The board says Ozari Health. What the board cannot say is whether the advertised figures you were shown elsewhere match these — check the gap row, because a listing that advertises low and bills high will beat an honest one in any comparison built on advertised prices.

    The verdict

    On the board, Ozari Health at $125 a month is the more defensible choice on arithmetic alone. TrimRx earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Ozari Health and TrimRx.

    How they sit against everyone else

    ProgrammeAdvertisedBilledGapVs board floor
    Coreage Rx$149$199+$50+$74/mo
    Trimi$125$125none—
    Ozari Health$125$125none—
    Fifty 410$133$133none+$8/mo

    More from the desk

    • Ozari Health tirzepatide review

      Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.

    • TrimRx tirzepatide review

      Advertised at $349, billed at $399. Position 13 of 18 on our board.

    • How to spot a bad seller

      The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.

    • The twelve-month cost

      Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.

    • Cheapest right now

      Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.

    Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure